CORC

在结果中检索

CORC

浏览/检索结果: 共32条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文
BLOOD ADVANCES, 2023, 卷号: 7
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
收藏  |  浏览/下载：14/0  |  提交时间：2023/11/10
Crosstalk between the gut microbiome and clinical response in locally advanced thoracic esophageal squamous cell carcinoma during neoadjuvant camrelizumab and chemotherapy 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2022
作者:  Xu, Liwei;  Qi, Yajun;  Jiang, Youhua;  Ji, Yongling;  Zhao, Qiang
收藏  |  浏览/下载：30/0  |  提交时间：2022/05/05
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：29/0  |  提交时间：2022/05/05
A Support Vector Machine Based on Liquid Immune Profiling Predicts Major Pathological Response to Chemotherapy Plus Anti-PD-1/PD-L1 as a Neoadjuvant Treatment for Patients With Resectable Non-Small Cell Lung Cancer 期刊论文
FRONTIERS IN IMMUNOLOGY, 2021, 卷号: 12
作者:  Peng, Jie;  Zou, Dan;  Han, Lijie;  Yin, Zuomin;  Hu, Xiao
收藏  |  浏览/下载：23/0  |  提交时间：2022/02/14
Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China 期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:  Zhang, Xiangyu;  Zeng, Liang;  Li, Yizhi;  Xu, Qinqin;  Yang, Haiyan
收藏  |  浏览/下载：29/0  |  提交时间：2021/03/15
Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer 期刊论文
NANO TODAY, 2021, 卷号: 36, 页码: 12
作者:  Zhou, Fengqi;  Gao, Jing;  Xu, Zhiai;  Li, Tianliang;  Gao, Ang
收藏  |  浏览/下载：25/0  |  提交时间：2021/06/11
The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma 期刊论文
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 卷号: 12
作者:  Shen, Dijian;  Chen, Qixun;  Wu, Jie;  Li, Jianqiang;  Tao, Kaiyi
收藏  |  浏览/下载：36/0  |  提交时间：2021/04/26
Safety and efficacy of combination therapy using programmed cell death protein-1/programmed cell death ligand-1 inhibitors and radiotherapy in patients with non-small-cell lung cancer: A systematic review and meta-analysis 期刊论文
CANCER MEDICINE, 2021, 页码: 19
作者:  Geng, Yichao;  Zhang, Qiuning;  Feng, Shuangwu;  Li, Chengcheng;  Wang, Lina
收藏  |  浏览/下载：26/0  |  提交时间：2021/12/10
Immune Checkpoint Blockade in Cancer Immunotherapy: Mechanisms, Clinical Outcomes, and Safety Profiles of PD-1/PD-L1 Inhibitors 期刊论文
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2020, 卷号: 68, 期号: 6, 页码: 15
作者:  Yan, Yan;  Zhang, Li;  Zuo, Yun;  Qian, Heya;  Liu, Chang
收藏  |  浏览/下载：19/0  |  提交时间：2021/05/24
Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen 期刊论文
NATURE BIOMEDICAL ENGINEERING, 2020, 页码: 19
作者:  Xie, Xiaoling;  Hu, Yuxing;  Ye, Tong;  Chen, Yiran;  Zhou, Lijuan
收藏  |  浏览/下载：16/0  |  提交时间：2021/03/29

©版权所有 ©2017 CSpace - Powered by CSpace